NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

299

Participants

Timeline

Start Date

November 24, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2026

Conditions
Lung Cancer, Small CellLung Cancer MetastaticLung Cancer RecurrentTreatment Side EffectsLung Cancer, Non-small CellNutritional Imbalance
Interventions
BEHAVIORAL

Nutritional Counseling

Medical oncology providers will refer participants to oncology RDs for remotely delivered medical nutrition therapy counseling. For cohort 1, participants will receive nutrition counseling for 8 months. The counseling will be provided on a weekly basis during the first 6 months and every other week during the last 2 months (for cohort 1 only). For cohort 2, participants will receive nutrition counseling for 6 months. The ultimate frequency of nutrition counseling being provided to each participant will also be adjusted according to the participant's preference and needs.

OTHER

Medically Tailored Meals (MTMs)

Medically tailored meals will be provided to participants in the intervention group for a total of 24 weeks for both cohorts. During the first 8 weeks of the intervention, 3 meals/day will be provided each week for a total of 168 meals per participant. It will be followed by less frequent meal provision during the subsequent 16 weeks following this schedule: 3 meals/day will be provided every other week for the next 8 weeks (a total of 84 meals per participant); and 3 meals/day will be provided every four weeks during the last 8 weeks (a total of 42 meals per participant). The number of meals provided to each participant may be adjusted according to participant's preference and needs.

BEHAVIORAL

Nutrition Prescription

Oncology providers will advise participants with lung cancer to follow evidence-based nutrition recommendations using a Nutrition Prescription. The Nutrition Prescription aims to enhance providers' role in communicating basic nutrition advice to participants with lung cancer. It contains seven recommendations, adapted from the newly released Cancer Prevention Recommendations by WCRF/AICR with strong evidence-base.

OTHER

Nutrition Assessment

Oncology care providers will assess the nutritional status of patients with lung cancer using PG-SGA Short Form (the Scored Patient-Generated Subjective Global Assessment). PG-SGA is an interdisciplinary patient assessment in oncology and other chronic catabolic conditions. The short form contains four patient generated historical components (weight history, food intake symptoms, and activities and function).

BEHAVIORAL

Nutrition Toolkit

Patients will receive a printed copy of a Nutrition Toolkit from providers. Evidence-based nutrition recommendations have been compiled for cancer survivors from 4 sources into a Nutrition Toolkit. The sources include: (1) AmericanCancer Society (ACS) Nutrition and Physical Activity Guidelines for Cancer Survivors; (2)World Cancer Research Fund / American Institute for Cancer Research (WFRF/AICR) Cancer Nutrition Guide; (3) National Cancer Institute (NCI) Eating Hints; and (4) National Comprehensive Cancer Network (NCCN) Guidelines for Cancer Survivors. The Nutrition Toolkit outlines topics about the impact of cancer treatment on dietary intake patterns and quality, strategies to manage treatment-related eating issues, maintaining a healthy weight post treatment, and evidence-based recommendations and practical. Nutrition Toolkit strategies for improving diet quality and maintaining an optimal weight for cancer survivors.

BEHAVIORAL

Monthly Emails

Monthly emails will be sent to participants to encourage the use of the toolkit with healthy recipes and general nutrition information.

Trial Locations (4)

19111

Fox Chase Cancer Center, Philadelphia

43210

The James Cancer Hospital, Columbus

77030

MD Anderson Cancer Center, Houston

02111

Tufts Medical Center, Boston

All Listed Sponsors
collaborator

Fox Chase Cancer Center

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Ohio State University

OTHER

collaborator

Tufts Medical Center

OTHER

lead

Tufts University

OTHER